Guidelines for hemophilia care.
The patient with hemophilia has a multitude of medical and psychosocial concerns. The HIV epidemic has drastically exacerbated his needs. Physicians must continue to educate themselves to keep apace of the rapidly changing treatments for hemophilia and for HIV detection and treatment. These recommendations highlight changes that have taken place in the past several months and are up-to-date as of July 1990. It is likely that they will change, however, as more information becomes known about current factor products and better care for HIV infections.
Mehta
P
P
Division of Pediatric Hematology/Oncology, University of Florida College of Medicine, JHMHC, Gainesville.
Saba
H
H
Lian
E
E
Davis
J
J
Cumming
W
W
Barrett
D
D
Sandler
E
E
Kalen
V
V
Kao
K J
KJ
Reiter
W
W
D015492:AIDS Serodiagnosis; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D002648:Child; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control; D006679:HIV Seropositivity; D006467:Hemophilia A / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D012747:Sexual Partners; D015215:Zidovudine / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D015215:Zidovudine